Concepedia

Publication | Open Access

A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma

DOIFull Paper Access

75

Citations

37

References

2016

Year

Abhijit Ray, Matthew A. Williams, Stephanie Meek, Randy C. Bowen, Kenneth F. Grossmann, Robert H.I. Andtbacka, Tawnya L. Bowles, John Hyngstrom, Sancy A. Leachman, Douglas Grossman,
Oncotarget

Abstract

Intratumoral injection with the combination of ipilimumab/IL-2 is well tolerated and generates responses in both injected and non-injected lesions in the majority of patients.

References

YearCitations

Page 1